Health Care/Hospital
United Imaging's Artificial Intelligence Subsidiary Wins in Facebook AI Research & NYU School of Medicine Global Competition
HOUSTON, Dec. 12, 2019 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, followed a strong appearance at the annual meeting of the Radiological Society ofNorth America (RSNA) with a win in a competition jointly organized by Facebook AI Researc...
iX Biopharma Reports on Outcome of Wafermine End-of-phase 2 Meeting with US FDA
SINGAPORE, Dec. 11, 2019 /PRNewswire/ -- Specialty pharmaceutical company iX Biopharma Ltd(SGX:42C) ("iX Biopharma" or, "the Company") is pleased to announce that it has successfully concluded an End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) regarding Wafermine, a sublin...
Breakthrough in Medical Electronics - A Novel Mixed & Augmented Reality Smart Glasses Surgical Navigation Solution
TAICHUNG, Dec. 10, 2019 /PRNewswire/ -- The mixed reality technology for surgery usually shown in the movies has now become a reality with the latest technological offering from theTaiwan-based company – Taiwan Main Orthopaedics Biotechnology and the branding name of medical devices is SURGLAS...
Gracell Announces Progressive Outcomes from Multiple Human Clinical Trials to Investigate FasTCAR and Dual CAR Cell Platform Technologies
SUZHOU, China and SHANGHAI, Dec. 9, 2019 /PRNewswire/ -- Gracell Biotechnologies Co., Ltd ("Gracell"), a clinical-stage immune cell therapy company, today announced the progressive clinical outcomes for leading product candidates FasTCAR-19, Dual CAR-19-22, and Dual CAR-BCMA-19 at the American...
BJ Bioscience Announces First Patient Dosed in FIH Trial of BJ-001 in Patients with Locally Advanced/Metastatic Solid Tumors
HANGZHOU, China, Dec. 9, 2019 /PRNewswire/ -- BJ Bioscience Inc. (the
'company') today announced that the first patient was successfully dosed on
December 4, 2019 in the first-in-human (FIH) trial of the company's BJ-001
program at NEXT ONCOLOGY inSan Antonio, Texas.
CARsgen Therapeutics Receives IND Clearance from the NMPA for AB011 Humanized Claudin18.2 Monoclonal Antibody
SHANGHAI, Dec. 9, 2019 /PRNewswire/ -- CARsgen Therapeutics, a clinical-stage biopharmaceutical company committed to discovering and developing a combined platform of Chimeric Antigen Receptor T (CAR-T) cell therapies and monoclonal antibodies for cancer, today announced that one of its leading d...
Korean ophthalmologist Oh Jungwoo performed '25 sec LASEK' in public for the first time
SEOUL, South Korea, Dec. 6, 2019 /PRNewswire/ -- Dr. Oh Jungwoo from Eos Eye Center in Gangnam-gu, Korea, revealed '25 sec LASEK' surgery publicly by video. This is the first time the operation has been released to the public and it shows Dr. Oh's surgery on a patient's left eye with minimal corn...
VolitionRx and Gyros Protein Technologies Awarded an Aggregate $1 million+ Eurostars Cash Grant to Collaborate on Developing a Lung Cancer Blood Test
AUSTIN, Texas, Dec. 5, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that it was awarded$820,000 (€740,000 Euros) and Gyros Protein Technologies AB, now part of Mesa Laboratories Inc. (NASDAQ:MLAB) was awarded$230,000 (€206,000 Euros) each in the form ...
Announcement of collaborative research agreement with National Cancer Center on analysis of gut bacteria related to cancer
TOKYO, Dec. 5, 2019 /PRNewswire/ -- bitBiome, Inc. (Representative Director: Yoshihito Daimon, "bitBiome") and National Cancer Center of Japan (President: Hitoshi Nakagama, Chuo-ku, Tokyo, "NCC") have signed a collaborative research agreement on the analysis of gut bacteria related to cancer onNo...
Huami Corporation Announced Corporate Mission: Connect Health with Technology
BEIJING, Dec. 4, 2019 /PRNewswire/ -- Huami Corporation ("Huami" or the "Company") (NYSE: HMI), a biometric and activity data-driven company with significant expertise in smart wearable technology, today hosted an annual press conference inBeijing, focusing on strategies. During the press confere...
Ping An Good Doctor and Merck KGaA, Darmstadt, Germany Form Strategic Collaboration to Advance Intelligent Healthcare in China
SHANGHAI, Dec. 4, 2019 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited (Stock code: "Ping An Good Doctor", 1833.HK) one of the world's leading healthcare ecosystem platforms, signed a strategic collaboration agreement today with Merck KGaA, Darmstadt,Germany, a leading science a...
North Pole Engineering Releases Runn Smart Treadmill Sensor
MINNEAPOLIS, Dec. 3, 2019 /PRNewswire/ -- North Pole Engineering announces the Runn™ smart treadmill sensor, a wireless speed, incline and cadence sensor for use with virtually any treadmill. Capturing treadmill workout data in real-time, Runn wirelessly communicates with mobile apps and wearable...
VolitionRx Limited Announces Proof of Concept Data in Lymphoma and Leukemia
AUSTIN, Texas, Dec. 3, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced results from its latest proof of concept study. A single pre-clinical Nu.Q™ assay utilizing a basic microtiter plate platform detected 80% of newly diagnosed Non-Hodgkins Lymphoma ("N...
United Imaging, BAMF Health Bring Bold Vision to Life: Global Strategic Partnership Advances Theranostics and Precision Medicine
HOUSTON, Dec. 3, 2019 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, announced today a global, strategic partnership with BAMF Health, an organization that is achieving AI-enabled precision medicine through molecular imaging and theranostic...
Lumosa Announces FDA Acceptance of IND Application for LT1001, an Extended-Release Analgesic Injection - Lumosa to Initiate the Bridging Study in the US
TAIPEI, Dec. 3, 2019 /PRNewswire/ -- Opioid misuse, addiction, and overdoses have caused significant social and economic burdens leading to the opioid crisis. LT1001 (brand name Naldebain®) is a prodrug of nalbuphine, an abuse-free analgesic that has been marketed worldwide for decades. Naldebain...
New Early Breast Cancer Drug Approved by Singapore Health Sciences Authority
* NERLYNX® (neratinib) now approved in Singapore for HER2+ breast cancer patients following adjuvant trastuzumab-based therapy * NERLYNX is the first therapy in the Specialised Therapeutics' portfolio approved inSE Asia * Five-year follow up data show NERLYNX reduces risk of invasive disease...
Gowan Company Announces Acquisition of Two New Active Ingredients, Fenamidone and Pencycuron, from Bayer AG
Company Expanding its Global Fungicide Portfolio HARPENDEN, England, Dec. 2, 2019 /PRNewswire/ -- Gowan Crop Protection Limited, an affiliate of Gowan Company, L.L.C., announced today that it has entered into agreements with Bayer AG to acquire rights to the active ingredients Fenamidone and P...
CMAB Biopharma and Fapon Biopharma Sign Agreement to Develop and Manufacture a Biologic Oncology Asset
* The newly founded relationship will combine the research and development ingenuity of Fapon Biopharma with the state-of-art biologics manufacturing services offered by CMAB * CMAB will provide a full range of development and manufacturing services for Fapon Biopharma's biologic drug project...
Concord Medical Announces Changes to the Board
BEIJING, Dec. 2, 2019 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a specialty hospital management group and an operator of the network of radiotherapy and diagnostic imaging centers inChina, today announced the resignation of Mr. Sha...
Innovent Presents Co-developed Cancer-Fighting Tyvyt(R) (Sintilimab Injection) at CIIE 2019 with Eli Lilly
SUZHOU, China, Nov. 28, 2019 /PRNewswire/ -- Innovent Biologics (01801.HK), a multinational biopharmaceutical company, and Eli Lilly and Company presented their co-developed Tyvyt® (generic name: sintilimab injection), a fully human anti-programmed cell death protein 1 (anti-PD-1) monoclonal anti...
Week's Top Stories
Most Reposted
Agoda and TPB Philippines join hands to bring the world to the Philippines' shores
[Picked up by 350 media titles]
2024-09-18 11:30FETC International's MD Dr. Y.C. Chang Honored with the "Master Entrepreneur Award" at APEA 2024
[Picked up by 315 media titles]
2024-09-16 11:50Mox Capital Announces Strategic Support for Rapid-Scaling Startups Across Vietnam and Southeast Asia
[Picked up by 284 media titles]
2024-09-14 17:37Illumina and LGC Biosearch Technologies join forces to drive genomic innovation in agriculture
[Picked up by 283 media titles]
2024-09-19 14:00Watsons-Marlow unveils Qdos™ H-FLO and WMArchitectTM :Innovating fluid solutions for the chemical and biopharmaceutical industries respectively
[Picked up by 274 media titles]
2024-09-19 08:00